- Home
- CVKD vs FEMY Comparison
CVKD vs FEMY Comparison
Compare CVKD & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVKD
- FEMY
- Stock Information
- Founded
- CVKD 2022
- FEMY 2004
- Country
- CVKD United States
- FEMY United States
- Employees
- CVKD N/A
- FEMY N/A
- Industry
- CVKD Medicinal Chemicals and Botanical Products
- FEMY Medical/Dental Instruments
- Sector
- CVKD Health Care
- FEMY Health Care
- Exchange
- CVKD Nasdaq
- FEMY Nasdaq
- Market Cap
- CVKD 26.3M
- FEMY 24.9M
- IPO Year
- CVKD 2023
- FEMY 2021
- Fundamental
- Price
- CVKD $17.04
- FEMY $1.01
- Analyst Decision
- CVKD Strong Buy
- FEMY Strong Buy
- Analyst Count
- CVKD 2
- FEMY 3
- Target Price
- CVKD $46.00
- FEMY $10.00
- AVG Volume (30 Days)
- CVKD 84.2K
- FEMY 245.5K
- Earning Date
- CVKD 11-07-2024
- FEMY 11-12-2024
- Dividend Yield
- CVKD N/A
- FEMY N/A
- EPS Growth
- CVKD N/A
- FEMY N/A
- EPS
- CVKD N/A
- FEMY N/A
- Revenue
- CVKD N/A
- FEMY $1,260,643.00
- Revenue This Year
- CVKD N/A
- FEMY $135.27
- Revenue Next Year
- CVKD N/A
- FEMY $310.75
- P/E Ratio
- CVKD N/A
- FEMY N/A
- Revenue Growth
- CVKD N/A
- FEMY 15.33
- 52 Week Low
- CVKD $5.40
- FEMY $0.73
- 52 Week High
- CVKD $32.55
- FEMY $2.40
- Technical
- Relative Strength Index (RSI)
- CVKD 57.77
- FEMY 34.33
- Support Level
- CVKD $16.25
- FEMY $0.98
- Resistance Level
- CVKD $19.97
- FEMY $1.18
- Average True Range (ATR)
- CVKD 1.80
- FEMY 0.08
- MACD
- CVKD -0.04
- FEMY -0.03
- Stochastic Oscillator
- CVKD 54.70
- FEMY 4.76
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.
About FEMY Femasys Inc.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics.